These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17977611)

  • 1. "Radio-lucent" and "radio-opaque" coronary stents characterized by multislice computed tomography.
    Otsuka M; Tanimoto S; Sianos G; Kukreja N; Weustink AC; Serruys PW; De Feyter PJ
    Int J Cardiol; 2009 Feb; 132(1):e8-10. PubMed ID: 17977611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent.
    Ormiston JA; Webster MW; Armstrong G
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):128-31. PubMed ID: 17139655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
    Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
    Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.
    Tanimoto S; Serruys PW; Thuesen L; Dudek D; de Bruyne B; Chevalier B; Ormiston JA
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):515-23. PubMed ID: 17503509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.
    Serruys PW; Ormiston JA; Onuma Y; Regar E; Gonzalo N; Garcia-Garcia HM; Nieman K; Bruining N; Dorange C; Miquel-Hébert K; Veldhof S; Webster M; Thuesen L; Dudek D
    Lancet; 2009 Mar; 373(9667):897-910. PubMed ID: 19286089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culotte stenting with bioabsorbable everolimus-eluting stents.
    Ruzsa Z; van der Linden M; Van Mieghem NM; Regar E; Ligthart JM; Serruys P; van Geuns RJ
    Int J Cardiol; 2013 Sep; 168(2):e35-7. PubMed ID: 23735343
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative assessment of in-stent dimensions: a comparison of 64 and 16 detector multislice computed tomography to intravascular ultrasound.
    Beohar N; Robbins JD; Cavanaugh BJ; Ansari AH; Yaghmai V; Carr J; Davidson CJ
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):8-10. PubMed ID: 16764004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery stents in multislice computed tomography: in vitro artifact evaluation.
    Mahnken AH; Buecker A; Wildberger JE; Ruebben A; Stanzel S; Vogt F; Günther RW; Blindt R
    Invest Radiol; 2004 Jan; 39(1):27-33. PubMed ID: 14701986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patency of the right coronary artery following implantation of metallic stent demonstrated by multislice computed tomography.
    Funabashi N; Komiyama N; Komuro I
    Heart; 2005 Apr; 91(4):436. PubMed ID: 15772188
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart imaging: the accuracy of the 64-MSCT in the detection of coronary artery disease.
    Alessandri N; Di Matteo A; Rondoni G; Petrassi M; Tufani F; Ferrari R; Laghi A
    Eur Rev Med Pharmacol Sci; 2009; 13(3):163-71. PubMed ID: 19673166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-stent restenosis and multislice computed tomography: is the method ready to start?
    Martuscelli E; Razzini C; D'Eliseo A; Di Luozzo M; Mauro B; Romeo F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):377-80. PubMed ID: 17443107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial.
    Maeng M; Jensen LO; Galloe AM; Thayssen P; Christiansen EH; Hansen KN; Helqvist S; Botker HE; Lassen JF; Thuesen L
    Am J Cardiol; 2009 Feb; 103(3):345-9. PubMed ID: 19166687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive evaluation of coronary artery stents patency after PTCA: role of Multislice Computed Tomography.
    Ligabue G; Rossi R; Ratti C; Favali M; Modena MG; Romagnoli R
    Radiol Med; 2004; 108(1-2):128-37. PubMed ID: 15269696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of coronary stent in vitro on multislice computed tomography angiography: improved in-stent visibility by the use of 140-kV tube voltage.
    Suzuki S; Furui S; Kuwahara S; Kaminaga T; Yamauchi T; Kawasaki T; Konno K; Kozuma K; Isshiki T
    J Comput Assist Tomogr; 2007; 31(3):414-21. PubMed ID: 17538289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of assessment of coronary stent patency using 16-slice computed tomography.
    Schuijf JD; Bax JJ; Jukema JW; Lamb HJ; Warda HM; Vliegen HW; de Roos A; van der Wall EE
    Am J Cardiol; 2004 Aug; 94(4):427-30. PubMed ID: 15325923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive multislice computed tomography coronary angiography for imaging coronary arteries, stents and bypass grafts.
    Soon KH; Kelly AM; Cox N; Chaitowitz I; Bell KW; Lim YL
    Intern Med J; 2006 Jan; 36(1):43-50. PubMed ID: 16409312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.